|
|
||||||||
Molecular Diagnostics and Genetics |
1
Fondation Jean Dausset CEPH, 27 avenue Juliette Dodu, 75010 Paris, France.
2
Laboratoire de Biochimie A, Hôpital Saint-Antoine,
AP-HP 75571 Paris Cedex 12, France.
3
Laboratoire de Biochimie et Glycobiologie,
Université René Descartes, UFR-Pharmacie, 4 avenue de
l'Observatoire, 75270 Paris Cedex 06, France.
a Address correspondence to this author at: Laboratoire de Biochimie A, Hôpital Saint-Antoine, 184, rue du Fbg Saint-Antoine, 75571 Paris Cedex 12, France. Fax 33-1 49 28 20 77; e-mail bruno.baudin{at}sat.ap-hop-paris.fr.
We have determined serum activity and kinetic constants of angiotensin I-converting enzyme (ACE), parallel to an insertion/deletion (I/D) polymorphism in its gene, in French centenarians and controls 2070 years of age because this enzyme could have an impact on cardiovascular risk, and thus on longevity. Both the ACE D allele and ACE D/D genotype were more frequent in centenarians in comparison with controls, without sex-related differences nor significant correlation with a cardiovascular pathology. In centenarians, I/D polymorphism was correlated with circulating ACE activity (D/D genotype, 89.0 ± 36.8 U/L; I/D genotype, 63.5 ± 26.0 U/L; and I/I genotype, 55.1 ± 39.4 U/L). The Michaelis constants for two substrates were identical whatever the genotype and were not different between centenarians and controls, i.e., 0.30 ± 0.03 mmol/L for furylacryloyl-phenylalanyl-glycyl-glycine and 1.35 ± 0.05 mmol/L for hippuryl-histidyl-leucine; for the latter, the optimal pH and activating concentration of chloride did not depend on I/D polymorphism. The maximal velocities with both substrates reflected the distribution of serum ACE activity as a function of the genotypes, in centenarians and in controls. In conclusion, plasma ACE activity is subject to a similar genotypic influence in centenarians as in adults 2070 years of age; however, ACE itself appears to be functionally similar for each genotype. Furthermore, the D allele as well as the higher serum ACE activities associated with the D/D genotype cannot discriminate individuals at high risk for cardiovascular diseases, major causes of mortality before the age of 100 years.
The following articles in journals at HighWire Press have cited this article:
![]() |
D. Melzer, A. J. Hurst, and T. Frayling Genetic Variation and Human Aging: Progress and Prospects J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2007; 62(3): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hodroj, L. Legedz, N. Foudi, C. Cerutti, M.-C. Bourdillon, P. Feugier, M. Beylot, J. Randon, and G. Bricca Increased Insulin-Stimulated Expression of Arterial Angiotensinogen and Angiotensin Type 1 Receptor in Patients With Type 2 Diabetes Mellitus and Atheroma Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 525 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seripa, M. Franceschi, M. G. Matera, F. Panza, P. G. Kehoe, C. Gravina, G. Orsitto, V. Solfrizzi, G. Di Minno, B. Dallapiccola, et al. Sex differences in the association of apolipoprotein e and Angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from southern Italy. J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 918 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Elkins, V. C. Douglas, and S. C. Johnston Alzheimer disease risk and genetic variation in ACE: A meta-analysis Neurology, February 10, 2004; 62(3): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rahmutula, T. Nakayama, Y. Izumi, Y. Ozawa, H. Shimabukuro, H. Kawamura, S. Zhen-Wang, J. Xiong-Wang, M. Aisa, C. Run-Yang, et al. Angiotensin-Converting Enzyme Gene and Longevity in the Xin Jiang Uighur Autonomous Region of China: An Association Study J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M57 - 60. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |